Jiangsu Hengrui Medicine (Jiangsu Hengrui) - Chinese pharmaceutical company. The headquarters is located in Lianyungang City. It was ranked 1,020th on the Forbes Global 2000 list of the world's largest public companies for 2021.

The Company Statement
December 06, 2023

"Petrovax," formerly owned by Vladimir Potanin's "Interros" until last year, has reached an agreement with the Chinese company Jiangsu Hengrui regarding the supply and subsequent localization of several oncology drugs, including camrelizumab, belonging to the same class as the American MSD's "Keytruda."

All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.